Chikungunya: a decade of burden in the Americas.

Autor:	de Souza WM; Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, College of Medicine, Lexington, KY, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.; Global Virus Network, Baltimore, MD, USA., Ribeiro GS; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil.; Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil., de Lima STS; Laboratório Central de Saúde Pública do Ceará, Fortaleza, Ceará, Brazil.; Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, São Paulo, Brazil., de Jesus R; Coordenação Geral dos Laboratórios de Saúde Pública, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brazil.; Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Moreira FRR; Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil., Whittaker C; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK., Sallum MAM; Departamento de Epidemiologia, Faculdade de Saúde Pública, Universidade de São Paulo, Brazil., Carrington CVF; Department of Preclinical Sciences, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Republic of Trinidad and Tobago., Sabino EC; Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.; Departamento de Moléstias Infecciosas e Parasitárias, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Kitron U; Department of Environmental Sciences, Emory University, Atlanta, GA, USA., Faria NR; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.; Instituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.; Department of Biology, University of Oxford, Oxford, UK., Weaver SC; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.; Global Virus Network, Baltimore, MD, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Jazyk:	angličtina
Zdroj:	Lancet regional health. Americas [Lancet Reg Health Am] 2024 Jan 08; Vol. 30, pp. 100673. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2024).
DOI:	10.1016/j.lana.2023.100673
Abstrakt:	In the Americas, one decade following its emergence in 2013, chikungunya virus (CHIKV) continues to spread and cause epidemics across the region. To date, 3.7 million suspected and laboratory-confirmed chikungunya cases have been reported in 50 countries or territories in the Americas. Here, we outline the current status and epidemiological aspects of chikungunya in the Americas and discuss prospects for future research and public health strategies to combat CHIKV in the region. Competing Interests: The authors declare no conflict of interest. (© 2024 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu